Northern Trust Stock: Is NTRS Outperforming the Financial Sector?
With a market cap of $21.6 billion, Northern Trust Corporation (NTRS) is a leading U.S. financial services firm based in Chicago. It serves institutions, ultra-high-net-worth individuals, and corporations globally through its Asset Servicing and Wealth Management segments.
Companies worth $10 billion or more are generally described as 'large-cap stocks,' and Northern Trust fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size and influence in the asset management industry. With a dominant position in servicing trillions in institutional assets and a lean towards innovation, it stands as a pillar in global financial infrastructure.
2 Outstanding Stocks Under $50 to Buy and Hold Now
Nvidia's Bringing Sovereign AI to Germany. Should You Buy NVDA Stock Here?
A $1 Billion Reason to Buy MicroStrategy Stock Here
Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines.
NTRS touched its two-year high of $114.67 on Feb. 7 and is currently trading 3.2% below that peak. NTRS has rallied 12.9% over the past three months, underperforming the Financial Select Sector SPDR Fund's (XLF) 2.4% rise over the same time frame.
NTRS stock has soared 8.3% on a YTD basis and 33.9% over the past 52 weeks, notably outperforming XLF's 3.9% uptick in 2025 and 21.7% returns over the past year.
To confirm the overall bullish trend, NTRS has traded consistently above its 50-day and 200-day moving averages since early May.
On June 18, Northern Trust shares gained over 1% as bank stocks rallied following reports that U.S. regulators may ease capital rules restricting Treasury trading.
In the financial services sector, Northern Trust has significantly outperformed its peer T. Rowe Price Group, Inc.'s (TROW) 18.5% decline in 2025 and a 21.6% drop over the past 52 weeks.
However, analysts remain cautious about the stock's prospects. Among the 15 analysts covering the NTRS stock, the consensus rating is a 'Hold,' and it currently trades above its mean price target of $107.11.
On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 hours ago
- Yahoo
Is Labcorp Holdings Stock Outperforming the Dow?
With a market cap of $21.9 billion, Labcorp Holdings Inc. (LH) provides laboratory services, aiding doctors, hospitals, pharmaceutical companies, researchers, and patients. Based in Burlington, North Carolina, the company operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. Companies worth $10 billion or more are typically referred to as "large-cap stocks." LH fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size and influence in the diagnostics & research industry. 2 Outstanding Stocks Under $50 to Buy and Hold Now Nvidia's Bringing Sovereign AI to Germany. Should You Buy NVDA Stock Here? A $1 Billion Reason to Buy MicroStrategy Stock Here Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market analysis you won't find anywhere else. The company is currently trading 1% below its 52-week high of $264.03 met on Jun. 16. LH shares have grown 9.1% over the past three months, outperforming the broader Dow Jones Industrial Average's ($DOWI) 1.4% rise during the same time frame. LH shares have surged 14% year-to-date, outperforming the Dow Jones Industrial Average's marginal pullback during the same period. Moreover, over the past 12 months, LH has delivered a solid 26.6% return, outpacing the Dow's 8.6% gain and showcasing its longer-term strength. To confirm its bullish trend, LH has been trading above its 200-day and 50-day moving averages since late April. LH shares rose 4.7% following the release of its Q1 earnings on Apr. 29. The company posted a revenue of $3.4 billion, falling behind the Street's estimates. Moreover, its adjusted EPS of $3.84 beat the consensus estimate by 3%, driven by 6% growth in its Diagnostics Laboratories business to $2.6 billion. Its peer, Natera, Inc. (NTRA) has grown 8% in 2025 and 58.3% over the past year, outperforming the stock. Among the 17 analysts covering the LH stock, the consensus rating is a 'Strong Buy.' Its mean price target of $277.24 suggests a modest 6.1% upside potential from current price levels. On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Sign in to access your portfolio
Yahoo
15 hours ago
- Yahoo
Is J.B. Hunt Transport Stock Underperforming the S&P 500?
Lowell, Arkansas-based J.B. Hunt Transport Services, Inc. (JBHT) provides surface transportation, delivery, and logistics services in the United States. With a market cap of $13.8 billion, the company operates through five segments: Intermodal (JBI), Dedicated Contract Services (DCS), Integrated Capacity Solutions (ICS), Final Mile Services (FMS), and Truckload (JBT). Companies worth $10 billion or more are typically referred to as "large-cap stocks." JBHT fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size and influence in the integrated freight & logistics industry. 2 Outstanding Stocks Under $50 to Buy and Hold Now Nvidia's Bringing Sovereign AI to Germany. Should You Buy NVDA Stock Here? A $1 Billion Reason to Buy MicroStrategy Stock Here Our exclusive Barchart Brief newsletter is your FREE midday guide to what's moving stocks, sectors, and investor sentiment - delivered right when you need the info most. Subscribe today! Despite its strengths, the stock has dipped 30.6% from its 52-week high of $200.40 touched on Nov. 11, 2024. Moreover, over the past three months, JBHT stock has declined 5.5%, underperforming the S&P 500 Index's ($SPX) 5.4% uptick during the same time frame. JBHT stock has declined 18.6% on a YTD basis, underperforming SPX's 1.7% uptick in 2025. Moreover, JBHT has declined 10.7% over the past 52 weeks, underperforming SPX's 9% gains. JBHT stock has been trading below its 200-day moving average since mid-February and mostly above its 50-day moving average since mid-May. On Apr. 15, JBHT stock declined 2% following the release of its Q1 earnings. The trucking and logistics company posted revenue of $2.92 billion in the period, which met Street forecasts. Moreover, its adjusted earnings for the quarter amounted to $1.17, surpassing the consensus estimates by 1.7%. Within the integrated freight & logistics industry, rival Expeditors International of Washington, Inc. (EXPD) has grown 2.1% in 2025 and has declined 9.2% over the past year, slightly outperforming the stock. Among the 24 analysts covering the JBHT stock, the consensus rating is a 'Moderate Buy.' Its mean price target of $151.33 suggests a modest 8.9% upside potential from current price levels. On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Sign in to access your portfolio
Yahoo
15 hours ago
- Yahoo
Is VeriSign Stock Outperforming the Dow?
VeriSign, Inc. (VRSN), headquartered in Reston, Virginia, is valued at $26.4 billion by market cap. The company delivers critical internet infrastructure services, including domain name registry and security, helping ensure smooth and secure navigation across globally recognized domain names. Companies worth $10 billion or more are generally categorized as 'large-cap stocks,' and VeriSign fits right into the category. It manages and operates the .com and .net domain name registries, helping to keep the internet running smoothly. It also operates two of the internet's 13 root DNS servers, playing a major role in global internet infrastructure. The company generates steady revenue from domain registrations and renewals and is recognized for its secure and reliable backend services. 2 Outstanding Stocks Under $50 to Buy and Hold Now Nvidia's Bringing Sovereign AI to Germany. Should You Buy NVDA Stock Here? A $1 Billion Reason to Buy MicroStrategy Stock Here Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market analysis you won't find anywhere else. VeriSign touched its 52-week high of $288.95 on May 7 and has retreated 2.7% from the peak. The stock has soared 17.2% over the past three months, outpacing the Dow Jones Industrials Average's ($DOWI) 1.4% gains during the same time frame. VeriSign has demonstrated impressive long-term strength, with its stock surging 35.9% in 2025 and delivering a remarkable 57.8% gain over the past 52 weeks, significantly outperforming the Dow Jones Industrial Average, which has posted a marginal year-to-date decline and just 8.6% growth over the same period. Reinforcing this bullish momentum, VRSN has consistently held above its 50-day and 200-day moving averages since late November 2024. VeriSign delivered a solid Q1 2025 performance on April 24, reporting a 4.7% year-over-year revenue increase to $402 million and an EPS of $2.10, surpassing analyst expectations. Net income climbed to $199 million, driven by the continued strength of its domain business, which saw a net addition of 0.78 million .com and .net domain names. Looking ahead, VeriSign raised its full-year revenue guidance to a range of $1.635–$1.650 billion and upgraded its domain base growth forecast. Encouraged by the strong results and upbeat outlook, VRSN shares rallied 8% in the subsequent trading session. VeriSign has notably outperformed its peer, GoDaddy Inc.'s (GDDY) 10.6% dip on a YTD basis and 28.7% rise over the past 52 weeks. Among the two analysts covering the VRSN stock, the consensus rating is a 'Strong Buy.' Its mean price target of $289.50 represents a modest 3% premium to current price levels. On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
